-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BCD-245 in Neuroblastoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BCD-245 in Neuroblastoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BCD-245 in Neuroblastoma Drug Details: BCD-245 is under development for treatment of neuroblastoma....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BCD-180 in Ankylosing Spondylitis (Bekhterev’s Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BCD-180 in Ankylosing Spondylitis (Bekhterev's Disease) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.BCD-180 in Ankylosing Spondylitis (Bekhterev's Disease) Drug Details:BCD-180 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HuMNC2-CAR22 in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HuMNC2-CAR22 in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HuMNC2-CAR22 in Triple-Negative Breast Cancer (TNBC) Drug Details: huMNC2-CAR22 (MUC1*-CAR-1XX)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Brexanolone in Anxiety Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Brexanolone in Anxiety Disorders report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Brexanolone in Anxiety Disorders Drug Details: Brexanolone is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – UCART20x22 in Marginal Zone B-cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - UCART20x22 in Marginal Zone B-cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. UCART20x22 in Marginal Zone B-cell Lymphoma Drug Details: Gene therapy...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nivolumab Biosimilar in Metastatic Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nivolumab Biosimilar in Metastatic Melanoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nivolumab Biosimilar in Metastatic Melanoma Drug Details: Nivolumab (BCD-263) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bis-5 in Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bis-5 in Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bis-5 in Lymphoma Drug Details: Bis5 (LB-1410) is under development for the...
-
Product Insights
CL-Viaduct Solar PV Park
CL-Viaduct Solar PV Park is a solar PV project located in Pennsylvania, United States. The project is owned and developed by BCD Project Holdings 1 LLC. The project is currently under construction. Empower your strategies with our CL-Viaduct Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections...
-
Product Insights
UN-School House Solar PV Park
UN-School House Solar PV Park is a solar PV project located in Pennsylvania, United States. The project is owned and developed by BCD Project Holdings 1 LLC. The project is currently under construction. Empower your strategies with our UN-School House Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Prolgolimab in Metastatic Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Prolgolimab in Metastatic Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Prolgolimab in Metastatic Melanoma Drug Details: Prolgolimab (Forteca) is a monoclonal...